121 related articles for article (PubMed ID: 1657743)
21. Are THC Levels in Oral Fluids and Blood Plasma Comparable after Oral Ingestion of Edibles Containing Cannabis or THC?
Madras BK
Clin Chem; 2017 Mar; 63(3):629-631. PubMed ID: 28188234
[No Abstract] [Full Text] [Related]
22. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
23. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
[TBL] [Abstract][Full Text] [Related]
24. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
Huestis MA; Barnes A; Smith ML
Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
[TBL] [Abstract][Full Text] [Related]
25. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
[TBL] [Abstract][Full Text] [Related]
26. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.
Cone EJ; Huestis MA
Ther Drug Monit; 1993 Dec; 15(6):527-32. PubMed ID: 8122288
[TBL] [Abstract][Full Text] [Related]
27. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke.
Mason AP; Perez-Reyes M; McBay AJ; Foltz RL
J Anal Toxicol; 1983; 7(4):172-4. PubMed ID: 6314043
[TBL] [Abstract][Full Text] [Related]
29. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
30. [Enzyme immunochemical detection of the use of hashish and confirmation by thin-layer chromatography].
von Meyer L
Z Rechtsmed; 1985; 94(3):219-25. PubMed ID: 2992188
[TBL] [Abstract][Full Text] [Related]
31. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
Skopp G; Pötsch L
J Anal Toxicol; 2008 Mar; 32(2):160-4. PubMed ID: 18334100
[TBL] [Abstract][Full Text] [Related]
33. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
34. The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Sørensen LK; Hasselstrøm JB
Drug Test Anal; 2018 Feb; 10(2):301-309. PubMed ID: 28570781
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid concentrations in blood and urine after smoking cannabidiol joints.
Meier U; Dussy F; Scheurer E; Mercer-Chalmers-Bender K; Hangartner S
Forensic Sci Int; 2018 Oct; 291():62-67. PubMed ID: 30149280
[TBL] [Abstract][Full Text] [Related]
37. Comparison of six cannabinoid metabolite assays.
Frederick DL; Green J; Fowler MW
J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
[TBL] [Abstract][Full Text] [Related]
38. Rapid reversed-phase high-performance liquid chromatographic method for the assay of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and confirmation of use of cannabis derivatives.
Bianchi V; Donzelli G
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):162-7. PubMed ID: 8634759
[TBL] [Abstract][Full Text] [Related]
39. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
[TBL] [Abstract][Full Text] [Related]
40. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
